3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow lorecivivint: new trials by email Literature Review of lorecivivint trials Research Report on lorecivivint
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis lorecivivint - Knee Osteoarthritis | Phase 2 | Terminated | Biosplice Therapeutics, Inc. | 13 | 2019-03-11 | 2026-03-04 |
| Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis Placebo, SM04690 - Knee Osteoarthritis | Phase 2 | Completed | Biosplice Therapeutics, Inc. | 101 | 2018-11-28 | 2026-01-12 |
| A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis SM04690, Placebo, Sham - Knee Osteoarthritis | Phase 2 | Completed | Biosplice Therapeutics, Inc. | 700 | 2017-04-24 | 2021-06-11 |
| A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects SM04690, Placebo - Osteoarthritis | Phase 2 | Completed | Biosplice Therapeutics, Inc. | 455 | 2015-09-09 | 2021-03-17 |
Osteoarthritis (4) · Osteoarthritis, Knee (3)
Biosplice Therapeutics, Inc. (4)
United States (4)
PMID 39495154, PMID 32432388, PMID 33588087, PMID 34101138, PMID 35005990